TR200102745T2 - New compounds - Google Patents

New compounds

Info

Publication number
TR200102745T2
TR200102745T2 TR2001/02745T TR200102745T TR200102745T2 TR 200102745 T2 TR200102745 T2 TR 200102745T2 TR 2001/02745 T TR2001/02745 T TR 2001/02745T TR 200102745 T TR200102745 T TR 200102745T TR 200102745 T2 TR200102745 T2 TR 200102745T2
Authority
TR
Turkey
Prior art keywords
polypeptides
new compounds
casb619
polynucleotides
methods
Prior art date
Application number
TR2001/02745T
Other languages
Turkish (tr)
Inventor
Elvire Bruck Claudine
Cassart Jean-Pol
Coche Thierry
Vinals Y De Bassols Carlota
Original Assignee
Smithkline Beecham Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9907113.6A external-priority patent/GB9907113D0/en
Priority claimed from GBGB9922858.7A external-priority patent/GB9922858D0/en
Application filed by Smithkline Beecham Biologicals S.A. filed Critical Smithkline Beecham Biologicals S.A.
Publication of TR200102745T2 publication Critical patent/TR200102745T2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Bu bulusta, CASB619 polipeptidler ve polinükleotidler ve bu polipeptidlerin rekombinant tekniklerle üretilmesine ilsikin yöntemler açiklanmaktadir. Ayrica, CASB619 polipeptidlerin ve polinükleotidlerin, kanserlerin, özellikle over ve kolon kanserlerinin, otoimmün hastaliklarin ve bunlarla ilgili tablolarin teshisinde ve bu hastaliklarin önleyici ve iyilestirici tedavisinde kullanilacak asilarin hazirlanmasinda kullanimina iliskin yöntemler de açiklanmaktadir.In this invention, CASB619 polypeptides and polynucleotides and methods for producing these polypeptides by recombinant techniques are described. Also disclosed are methods for the use of CASB619 polypeptides and polynucleotides, cancers, particularly ovarian and colon cancers, for the prevention and remedial treatment of autoimmune diseases and their tables.

TR2001/02745T 1999-03-26 2000-03-20 New compounds TR200102745T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9907113.6A GB9907113D0 (en) 1999-03-26 1999-03-26 Novel compounds
GBGB9922858.7A GB9922858D0 (en) 1999-09-25 1999-09-25 Novel compounds

Publications (1)

Publication Number Publication Date
TR200102745T2 true TR200102745T2 (en) 2002-05-21

Family

ID=26315346

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02745T TR200102745T2 (en) 1999-03-26 2000-03-20 New compounds

Country Status (17)

Country Link
EP (1) EP1165774A2 (en)
JP (1) JP2002539826A (en)
KR (1) KR20020008134A (en)
CN (1) CN1351661A (en)
AU (1) AU3430800A (en)
BR (1) BR0009358A (en)
CA (1) CA2368014A1 (en)
CZ (1) CZ20013466A3 (en)
HK (1) HK1044961A1 (en)
HU (1) HUP0202930A2 (en)
IL (1) IL145048A0 (en)
MX (1) MXPA01009688A (en)
NO (1) NO20014629L (en)
NZ (1) NZ513839A (en)
PL (1) PL351517A1 (en)
TR (1) TR200102745T2 (en)
WO (1) WO2000058460A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6951738B2 (en) 1999-07-16 2005-10-04 Human Genome Sciences, Inc. Human tumor necrosis factor receptors TR13 and TR14
FR2800388A1 (en) * 1999-10-29 2001-05-04 Pf Medicament CLONING, EXPRESSION AND CHARACTERIZATION OF A GENE EXPRESSED IN TUMOR CELLS AND INVOLVED IN REGULATION OF THE IMMUNE RESPONSE
JP2003252801A (en) * 2002-02-27 2003-09-10 Japan Science & Technology Corp Method for using pituitary-specific gene
EP1572118A4 (en) * 2002-12-20 2010-07-14 Millennium Pharm Inc Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216
WO2004085666A2 (en) * 2003-03-20 2004-10-07 Incyte Corporation Secreted proteins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
ES2267192T3 (en) * 1997-08-01 2007-03-01 Serono Genetics Institute S.A. ESTS 5 'FOR NON-SPECIFIC SECRETED TISSUE PROTEINS.
DE19817948A1 (en) * 1998-04-17 1999-10-21 Metagen Gesellschaft Fuer Genomforschung Mbh New nucleic acid sequences expressed in uterine cancer tissues, and derived polypeptides, for treatment of uterine and endometrial cancer and identification of therapeutic agents

Also Published As

Publication number Publication date
BR0009358A (en) 2002-04-23
KR20020008134A (en) 2002-01-29
IL145048A0 (en) 2002-06-30
PL351517A1 (en) 2003-04-22
WO2000058460A3 (en) 2000-12-28
JP2002539826A (en) 2002-11-26
EP1165774A2 (en) 2002-01-02
NO20014629L (en) 2001-11-26
MXPA01009688A (en) 2002-03-27
HUP0202930A2 (en) 2002-12-28
CN1351661A (en) 2002-05-29
CA2368014A1 (en) 2000-10-05
HK1044961A1 (en) 2002-11-08
NO20014629D0 (en) 2001-09-24
AU3430800A (en) 2000-10-16
WO2000058460A2 (en) 2000-10-05
CZ20013466A3 (en) 2002-02-13
NZ513839A (en) 2001-09-28

Similar Documents

Publication Publication Date Title
TR200102577T2 (en) Use of Casb616 Polypeptide and Polynucleotides for Cancer Treatment
TR200102745T2 (en) New compounds
TR200102781T2 (en) New compounds
GB9820003D0 (en) Novel compounds
GB9809683D0 (en) Novel compounds
DE69921649D1 (en) MORAXELLA CATARRHALIS PILQ PROTEINE
DK1078064T3 (en) Compounds from moraxella catarrhalis
TR200100741T2 (en) Moraxella catarrhalis BASB034 polypeptides and their use
DE60134253D1 (en) BASB205 POLYPEPTIDE AND POLYNUCLEOTIDE ENCODING THEREOF
GB9812440D0 (en) Novel compounds
ATE454452T1 (en) BASB118 POLYPEPTIDE AND POLYNUCLEOTIDE FROM MORAXELLA CATARRHALIS
GB0025170D0 (en) Novel compounds
GB9918302D0 (en) Novel compounds
GB9918003D0 (en) Novel compounds
ATE293693T1 (en) MORAXELLA CATARRHALIS ANTIGEN BASB117
DK1196586T3 (en) BASB111 polypeptide and polynucleotide from Moraxella catharralis
DE60019613D1 (en) MORAXELLA CATARRHALIS ANTIGEN BASB120
GB0025169D0 (en) Novel compounds
ATE274582T1 (en) BASB028 POLYPEPTIDES AND POLYNUCLEOTIDES CODING THEREFOR FROM MORAXELLA CATARRHALIS
ATE368686T1 (en) POLYPEPTIDES FROM MORAXELLA (BRANHAMELLA) CATARRHALIS